MLCI vs TECH · rev $11.4M vs P/E 65, rev $1.22B
Mount Logan Capital Inc. Common Stock (MLCI) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Mount Logan Capital Inc. Common Stock (MLCI) is a asset management company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MLCI revenue for 2025-09-30 was $11.4M. Net income was -$13.4M. Revenue was down 10.0% from 2024-09-30 to 2025-09-30. MLCI currently screens at market cap $30.8M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MLCI currently screens at market cap $30.8M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MLCI and TECH stock pages for the full models.
Not investment advice.